Literature DB >> 20580542

Gender and skeletal muscle characteristics in subjects with chronic obstructive pulmonary disease.

Sonia H Torres1, María Montes de Oca, Eduardo Loeb, Abdón Mata, Noelina Hernández.   

Abstract

BACKGROUND: The influence of gender in the clinical expression of COPD has received important attention. Limited information exists regarding gender differences in the skeletal muscle characteristics in COPD subjects. The present study was aimed to determine the differences in the skeletal muscle characteristics in men and women with and without COPD.
METHODS: For comparison we studied 24 female (61 ± 9 years) and 30 male (65 ± 8 years) COPD patients with similar disease severity. In addition healthy subjects, 17 women (58 ± 8 years), and 9 men (57 ± 8 years) were studied. Pulmonary function, health status, six minute walk distance test (6MWD) and vastus lateralis muscle biopsy were assessed. Fiber type proportion, fiber type cross sectional area (CSA), capillary counts, and activity of citrate synthase (CS), 3-hydroxyacyl-CoA-dehydrogenase (HAD) and lactate-dehydrogenase (LDH) were determined.
RESULTS: Pulmonary function, health status and 6MWD were similar in male and female COPD patients. Fiber type distribution was similar between women (I = 42 ± 9%, IIA = 39 ± 13%, IIX = 19 ± 7%) and men (I = 39 ± 13%, IIA = 38 ± 9%, IIX = 29 ± 10%) with COPD, as well as CSA, capillarity and enzymes (CS 8.59 ± 1.6 vs.9.74 ± 2.6, HAD 9.03 ± 1.9 vs. 9.84 ± 2.5, LDH 124 ± 48 vs. 151 ± 68 μmol min(-1) g(-1)). In normal subjects a decrease in type IIX fibers CSA was found in women compared with men (3703 ± 1478 vs. 5426 ± 1386 μm(2), respectively).
CONCLUSIONS: Female and male with COPD have similar skeletal muscle characteristics; it is possible that the disease blurs the gender differences. On the other hand, there seems to be fewer differences in muscle characteristics between older men and women, perhaps due to lower male testosterone levels and physical inactivity.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20580542     DOI: 10.1016/j.rmed.2010.05.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

Review 1.  Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets.

Authors:  Esther Barreiro; Ariel Jaitovich
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  The six-minute stepper test is related to muscle strength but cannot substitute for the one repetition maximum to prescribe strength training in patients with COPD.

Authors:  Tristan Bonnevie; Mathilde Allingham; Guillaume Prieur; Yann Combret; David Debeaumont; Maxime Patout; Antoine Cuvelier; Catherine Viacroze; Jean-François Muir; Clement Medrinal; Francis-Edouard Gravier
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-03-29

3.  Experience of fatigue, and its relationship to physical capacity and disease severity in men and women with COPD.

Authors:  Kristina Tödt; Elisabeth Skargren; Magnus Kentson; Kersti Theander; Per Jakobsson; Mitra Unosson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-12-16

4.  Isometric Strength Database for Muscle Maximal Voluntary Endurance Field Tests: Normative Data.

Authors:  Frédérick Janik; Claire Toulotte; Anne Laure Seichepine; Bernadette Masquelier; Fabienne Barbier; Claudine Fabre
Journal:  Sports Med Open       Date:  2021-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.